Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.
Revenue (Most Recent Fiscal Year) | $245.11M |
Net Income (Most Recent Fiscal Year) | $-204.62M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 6.30 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.80 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -77.99% |
Net Margin (Trailing 12 Months) | -78.44% |
Return on Equity (Trailing 12 Months) | -32.16% |
Return on Assets (Trailing 12 Months) | -26.09% |
Current Ratio (Most Recent Fiscal Quarter) | 5.98 |
Quick Ratio (Most Recent Fiscal Quarter) | 5.51 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 4.84 |
Book Value per Share (Most Recent Fiscal Quarter) | $10.86 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.75 |
Earnings per Share (Most Recent Fiscal Year) | $-3.62 |
Diluted Earnings per Share (Trailing 12 Months) | $-3.61 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Common Shares Outstanding | 57.82M |
Free Float | 55.55M |
Market Capitalization | $1.65B |
Average Volume (Last 20 Days) | 0.71M |
Beta (Past 60 Months) | 1.62 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.92% |
Percentage Held By Institutions (Latest 13F Reports) | -- |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |